Spinal disks are critical to the spine’s general health. A herniated disk can occur when the spine is put under continual strain. This injury can cause severe pain and discomfort, but it is treatable with stem cell therapy for degenerative disk disease.
Intervertebral disk (IVD) degeneration affects more than 70 per cent of adults under the age of 50 and more than 90 per cent of those over 50. Although IVD can be asymptomatic, the pain it causes, known as discogenic pain, accounts for 25 to 80 per cent of all low back and neck discomfort.
Intervertebral disk degeneration (IVD) is caused by changes in metabolism, biomechanics, and morphology. It is distinguished by cell death and extracellular matrix degradation. Neovascularization and nerve development are examples of the resulting microenvironmental changes, which can result in pain and decreased biomechanical function.
A herniated disk is a type of damaged spinal disk. These disks are located between each vertebra in the spine and serve as tiny cushions for the spine. They absorb impact to protect the spine’s bones from wear and strain.
Each spinal disk is made up of a robust outer layer called the annulus and a soft inner layer called the nucleus. When the nucleus bulges out from a split in the annulus, this is referred to as a herniated disk. Herniated disks can occur anywhere in the spine, and symptoms vary according to where they occur. If a herniated disk hits a nearby nerve, it can cause pain, numbness, tingling, and/or weakness in a leg or arm. If neglected, a disk injury can lead to chronic back discomfort.
Stem cell therapy has been shown to be a successful therapeutic option for a variety of orthopedic problems, including herniated disks. Stem cell treatment for a herniated disk may be utilized as a regenerative alternative to surgery for those who have prolonged pain. It works by directly infusing the patient’s stem cells into the ruptured disk. The injured tissue is repaired by stem cells over a few months, resulting in remarkable symptom alleviation.
Stem cell therapy for degenerative disk syndrome is a minimally invasive regenerative therapeutic option that allows patients to return to work within a few days of getting the stem cell injections. To transfer the stem cells into the injured disk, the ultra-precise spinal injections use image-guided procedures such as sophisticated X-ray fluoroscopy and ultrasound.
Stemwell uses cord tissue-derived mesenchymal stem cells ethically sourced from full-term human umbilical cords (We do not utilize cells from embryos). We then administer more than 300 million cells that are all thoroughly tested for viability before treatment. These cells are NOT a blood product; therefore, it is extremely safe and does not require HLA or phenotypic matching.
Video call with our patient advocates and our doctors where the patient’s condition and medical history will be discussed.
The patient undergoes an initial evaluation and blood work by Stemwell’s doctor.
Endovenous detox therapy applied to patient
Localized intrathecal stem cell injections in trigger pain points
Hyperbaric Chamber therapy – Hyperbaric oxygen reduces inflammation, oxygenates injured muscle, and regenerates skeletal muscle via macrophage and satellite cell activation.
Photobiomodulation (PBM Therapy) – the application of red and near infra-red light over injuries or lesions to improve wound and soft tissue healing, reduce inflammation and give relief for both acute and chronic pain.
*Each Protocol is customized to the patient depending their medical and surgical history
This protocol information is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, is for general information purposes only.
The body’s immune system is unable to recognize umbilical cord-derived mesenchymal stem cells as foreign and, therefore, they are not rejected. Mesenchymal stem cells have been administered thousands of times by our doctors and there has never been a single instance of rejection (graft vs. host disease). Indeed, allogeneic (not the patient’s own) mesenchymal stem cells are approved to treat graft vs. host disease in Canada and New Zealand.
Umbilical cord-derived mesenchymal stem cells also proliferate/differentiate more efficiently than “older” cells, such as those found in the fat and therefore, they are considered to be more “potent”.
The stem cells are administered by a licensed physician into the affected joint(s) (intra-articular injection) and intravenously (IV). In certain circumstances, stem cells may also be administered intrathecally and/or intramuscularly. Extra intra-articular injections for multiple joints can be arranged as medical requirements dictate.
Our mission is to bring hope, healing, and a personalized plan to every patient we meet. We believe the caring hands and expertise of our doctors along with our proven protocols provide the best possible outcomes. We follow the highest ethical international standards offering transparency, honesty, and clinical accuracy.
AddressCra. 13 #118-08, Bogotá, Colombia
Stem cell therapy offers no guarantees and is not promoted as a cure. This is similar to many other medical treatments. Reviewing the patient’s medical history is necessary to determine stem cell therapy eligibility. Any personal information provided is for internal and medical use with our medical providers only. The Stemwell Health headquarters is located in McLean, Virginia. Stemwell Health Virginia is not a stem cell treatment facility or surgical center. Treatments are not conducted anywhere in the US, since these advanced therapies are not yet FDA-approved. All cell therapies are conducted in Colombia where it is regulated by the ministry of health, INVIMA (Columbia’s FDA equivalent) and other local authorities. All treatments are performed within the country’s legal limits and regulatory framework where the specific medical provider practices.